Smart glasses company Viture had a busy 2025, releasing its solid Luma series of glasses and ensuring that its pro mobile ...
Try SAM 3D to create editable 3D models and meshes from images, with manual scale and rotate tools, helping beginners turn ...
Android Central on MSN
Xreal 1S brings 1200p visuals and a lower price to the best AR glasses
Xreal just reset the bar with the $449 1S, packing sharper 1200p visuals and instant 3D into a headset that finally makes AR ...
Battery X Metals has advanced the development of its next-generation, patent-pending lithium-ion battery rebalancing platform by completing a high-resolution 3D scan of a Tesla Model 3 battery pack, ...
European developers Orsted A/S and Equinor ASA filed legal challenges to the Trump administration’s decision to halt ...
Kulicke and Soffa stands out as rising AI-driven demand lifts electronics manufacturing stocks, even as macro pressures weigh ...
• The Federal Reserve cut interest rates Wednesday by a quarter point as expected, lowering borrowing costs for the third time this year. • Wall Street rallied after Fed Chair Jerome Powell ruled out ...
The Federal Reserve on Wednesday cut its benchmark interest rate by 0.25 percentage points, bringing the federal funds rate to its lowest level in more than three years. The reduction lowers the ...
Just a few weeks ago, the stock market stumbled over fears that artificial intelligence stocks might be in a bubble. Now stocks are back within reach of a record high. Thank the Federal Reserve. The ...
Carlyle cut spending on Copilot Studio due to data integration issues - report Big Tech under pressure to prove hefty AI investments are generating returns Microsoft shares pare losses after denial, ...
XREAL is wrapping up 2025 with the launch of a new entry-level AR glasses model, the XREAL 1S. It sits below the more expensive XREAL One Pro (announced in July) in the lineup and is the first in the ...
On the heels of striking a deal with the Trump administration to reduce the prices of several of its most popular drugs for U.S. patients, Eli Lilly has unveiled additional savings for cash-paying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback